NTAGI's Covid Working Group to Review SII's Covovax Data for Use in 12 Year Olds and Above India's drug regulator had approved Covovax for restricted use in emergency situations in adults on December 28 and in the 12 to 17 years age group subject to certain conditions on March 9
